Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer
Errataetall: |
ErratumFor: Br J Cancer. 2016 Mar 29;114(7):723-30. - PMID 27002934 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
---|---|
Enthalten in: |
British journal of cancer - 114(2016), 12 vom: 14. Juni, Seite e21 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Drew, Yvette [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 20.11.2019 published: Print-Electronic ErratumFor: Br J Cancer. 2016 Mar 29;114(7):723-30. - PMID 27002934 Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1038/bjc.2016.133 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM260771201 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM260771201 | ||
003 | DE-627 | ||
005 | 20231224194122.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/bjc.2016.133 |2 doi | |
028 | 5 | 2 | |a pubmed24n0869.xml |
035 | |a (DE-627)NLM260771201 | ||
035 | |a (NLM)27228289 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Drew, Yvette |e verfasserin |4 aut | |
245 | 1 | 0 | |a Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.11.2019 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumFor: Br J Cancer. 2016 Mar 29;114(7):723-30. - PMID 27002934 | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Published Erratum | |
700 | 1 | |a Ledermann, Jonathan |e verfasserin |4 aut | |
700 | 1 | |a Hall, Geoff |e verfasserin |4 aut | |
700 | 1 | |a Rea, Daniel |e verfasserin |4 aut | |
700 | 1 | |a Glasspool, Ros |e verfasserin |4 aut | |
700 | 1 | |a Highley, Martin |e verfasserin |4 aut | |
700 | 1 | |a Jayson, Gordon |e verfasserin |4 aut | |
700 | 1 | |a Sludden, Julieann |e verfasserin |4 aut | |
700 | 1 | |a Murray, James |e verfasserin |4 aut | |
700 | 1 | |a Jamieson, David |e verfasserin |4 aut | |
700 | 1 | |a Halford, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Acton, Gary |e verfasserin |4 aut | |
700 | 1 | |a Backholer, Zoe |e verfasserin |4 aut | |
700 | 1 | |a Mangano, Raffaella |e verfasserin |4 aut | |
700 | 1 | |a Boddy, Alan |e verfasserin |4 aut | |
700 | 1 | |a Curtin, Nicola |e verfasserin |4 aut | |
700 | 1 | |a Plummer, Ruth |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d 1947 |g 114(2016), 12 vom: 14. Juni, Seite e21 |w (DE-627)NLM000027537 |x 1532-1827 |7 nnns |
773 | 1 | 8 | |g volume:114 |g year:2016 |g number:12 |g day:14 |g month:06 |g pages:e21 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/bjc.2016.133 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 114 |j 2016 |e 12 |b 14 |c 06 |h e21 |